Hemosiderin Removal Composition Using Phytic Acid and Bromelain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bruising and swelling after surgery or skin injury do not effectively address the removal of hemosiderin, which causes skin discoloration, and often involve conventional medications that can be oxidized before absorption, necessitating a safer, natural composition for rapid bruise resolution.
Innovation Solution
A skin treatment composition comprising a chelating agent like phytic acid and a protease such as bromelain, combined with natural extracts like Arnica montana, for oral or topical administration, to selectively remove hemosiderin and reduce inflammation and pain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medications are used to treat bruising, then inflammation and pain are reduced, but the medications can be oxidized before absorption and do not effectively remove hemosiderin
Solution Approach 1:
The patent changes the chemical parameters of the treatment by using natural ingredients with different stability profiles. Vitamin C is used in controlled amounts with stabilizers, and natural anti-inflammatories like bromelain and curcumin are employed instead of conventional NSAIDs, altering the chemical stability and absorption characteristics of the treatment composition.
Solution Approach 2:
The patent converts the potential harm of oxidation into benefit by using natural antioxidants like vitamin E and green tea extract that work synergistically with vitamin C. These antioxidants protect the active ingredients from premature oxidation while also providing therapeutic benefits for bruise healing, turning a potential problem into a therapeutic advantage.
2Ease of operation
If topical formulations are applied to treat bruising, then local treatment is provided, but active ingredients are easily removed or oxidized before absorption by skin
Solution Approach 1:
The patent creates a composite topical formulation combining multiple natural ingredients (vitamin C, vitamin E, green tea extract, bromelain, curcumin) with stabilizing agents like hyaluronic acid and aloe vera. This composite structure provides mutual protection against oxidation while enhancing penetration and retention on the skin, allowing local treatment with improved reliability of active ingredient delivery.
Solution Approach 2:
The patent uses stabilizing agents like hyaluronic acid and aloe vera as intermediaries that facilitate the delivery and retention of active ingredients on the skin. These mediators create a protective matrix that prevents premature removal and oxidation while enabling controlled release and absorption of the therapeutic components.
3Reliability
If oral compositions are used to treat bruising, then systemic treatment is provided, but the composition must be safe for concurrent use with conventional medicines
Solution Approach 1:
The patent employs short-acting natural ingredients that provide therapeutic effects during the acute bruising phase (typically 1-2 weeks) without accumulating in the body. Ingredients like bromelain, curcumin, and vitamin C have relatively short half-lives and are rapidly metabolized, minimizing the window for drug interactions while providing effective systemic treatment for the duration needed.
Solution Approach 2:
The patent changes the pharmacological parameters by using natural ingredients with different metabolic pathways and lower potential for drug interactions compared to conventional medications. The dosages are optimized to provide therapeutic levels during the acute phase while maintaining safety margins that reduce interaction risks with conventional medicines.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition accelerates the removal of hemosiderin, shortens bruise duration, reduces inflammation, and promotes healing, while being safe for concurrent use with conventional medicines.
Implementation Method 1
comprising a chelating agent and at least one protease
Implementation Method 2
comprising a chelating agent and at least one protease
Data Source
AI summary
There is provided a skin treatment composition for oral or topical administration and a method for skin treatment. The composition comprises a chelating agent and at least one protease. The composition helps to remove hemosiderin that causes staining of skin on a bruised area and reduces inflammation and pain.